Term
Common Pathogens of Cellulitis |
|
Definition
Group A Beta Hemolytic Strep. pyogenes
Staphylcoccus aureus, historically MSSA |
|
|
Term
|
Definition
Anti-Staph Penicillinase Resistant
Dicloxacin PO
Nafcillin IV
Oxacillin IV
1st Gen Cephalosporins
Cephalexin PO
Cefazolin IV
Allergic Patients:
Clindamycin (causes C. diff overgrowth)
Macrolides (resistance developing) |
|
|
Term
Duration of Treatment for Cellulitis |
|
Definition
Short duration: 7-10 days |
|
|
Term
Treatment of CA-MRSA Cellulitis |
|
Definition
Bactrim
Clindamycin
Doxycycline
Vancomycin and newer MRSA agents best for severe infections
Avoid fluoroquinolones (resistance developing) |
|
|
Term
|
Definition
Group A Hemolytic Strep. pyogenes
Staph. aureus (MSSA) |
|
|
Term
|
Definition
Anti-Staph Penicillinase Resistant
Dicloxacin PO
Nafcillin IV
Oxacillin IV
1st Gen Cephalosporins
Cephalexin PO
Cefazolin IV
Allergic Patients:
Clindamycin (causes C. diff overgrowth)
Macrolides (resistance developing) |
|
|
Term
Duration of Therapy for Impetigo |
|
Definition
|
|
Term
Characteristics of Erysipelas |
|
Definition
- Superficial Cellulitis with extensive lymphatic involvement
- Borders well defined by elevation
- Lower extremities most common
|
|
|
Term
|
Definition
Group A Beta Hemolytic Strep pyogens (primarily)
Rarely:
Group B Beta Hemolytic Strep agalactiae in newborns
Staph. aureus
|
|
|
Term
|
Definition
DOC: Penicillin (any will work) -- IV, IM, or PO depending on severity
Anti-Staph Penicillins, Cephalosporins are also OK
Allergy to Beta Lactams:
Clindamycin or Macrolide
Keep in mind: dying organisms release toxins so infection might appear to worsen with treatment
|
|
|
Term
Duration of Erysipelas Treatment |
|
Definition
|
|
Term
|
Definition
Group A Strep, Staph. aureus, or Clostridium
Can produce deadly toxins
For serious infection combine:
Beta-Lactam or Cell wall agent with Clindamycin
Possible with Linezolid (for MRSA) too |
|
|
Term
Characteristics of Necrotizing Soft Tissue Infections |
|
Definition
- Rare, but very serious
- Progressive destruction of fascia, subcutaneous fat, and muscle
- Most frequently occurs below the diaphragm (abdomen, perineum, lower extremities)
|
|
|
Term
Predisposing Condition for Necrotizing Soft Tissue Infections |
|
Definition
- Diabetes
- Surgery/Local Trauma
- Recent infections
|
|
|
Term
Pathogens of Necrotizing Soft Tissue Infections |
|
Definition
Bacteroides
Peptostreptococcus
Streptococci
Enterobacteriaceae
Group A Beta Hemolytic Strep pyogenes
Clostridium perfringens |
|
|
Term
Empirical Treatment of Necrotizing Soft Tissue Infections |
|
Definition
Surgical Debridement Plus:
(you need something with G+, G-, and Anaerobic activity)
Penicillin/Beta-Lactamase Inhibitor
OR
Carbepenems
PLUS:
Vancomycin or alternative (linezolid)
+/-
Clindamycin or Metronidazole (for abcess)
|
|
|
Term
Common Pathogens of Diabetic Foot Infections |
|
Definition
- Often Polymicrobic
- Staph and Strep very common
- G- (E.coli, Klebsiella, Proteus, P. aeruginosa)
- Anaerobes (Bacterioides frigalis, Peptostreptococcus)
G- love moist, dark places
Anaerobes live in harmony with aerobes, poor O2 supply to site of infection |
|
|
Term
Treatment of Diabetic Foot Infections |
|
Definition
- Mild cases similar to cellulitis treatment
Amoxicillin/Clavulanate PO
Ampicillin/Sulbactam IV
Ertapenem IV
- Severe/Life-Threatening Infections
Imipenem/Doripenem/Moripenem IV
Piperacillin/Tazobactam
- Other Options (for allergic patients)
Clindamycin plus Ciprofloxacin or Aztreonam
Levofloxacin plus metronidazole
Moxifloxacin |
|
|
Term
Duration of Treatment for Diabetic Foot Infections |
|
Definition
10-14 days if mild-moderate
21 days if severe |
|
|
Term
Treatment for Severe/Life Threatening Diabetic Foot Infections |
|
Definition
Imipenem, Doripenem, Meropenem
Piperacillin/Tazobactam |
|
|
Term
Treatment for Diabetic Foot Infections in patients that have allergies to beta-lactams |
|
Definition
- Clindamycin + Ciprofloxacin or Aztreonam
- Levofloxacin + Metronidazole
- Possibly Moxifloxacin alone (Strep., Enteric, and Anaerobe activity)
|
|
|
Term
If MRSA is suspected in a Diabetic Foot Infection, treat with: |
|
Definition
|
|
Term
|
Definition
Topical for minor sores:
Silver sulfadiazine, mafenide for burns
Triple Antibiotic Ointment (neomycin, bacitracin, polymyxin)
Systemic for severe sores:
Same as for polymicrobial infections
G+, G-, and Anaerobes
|
|
|
Term
Common Pathogens of Bites |
|
Definition
Staph and Strep
G-
Anaerobes if deep |
|
|
Term
|
Definition
|
|
Term
|
Definition
Biospy, Culture from Surgery
Elevated WBCs, ESR, and CRP
Imaging |
|
|
Term
|
Definition
Hematogenous
Infection spreads through bloodstream
Usually in long bones of children
Vertebral in adults over 50
Contiguous
Infection spreads from adjoining tissue
Penetrating Trauma
Pressure Ulcers |
|
|
Term
Common Pathogens of Hematogenous Osteomyelitis |
|
Definition
Children
S. aureus moss prevalent (MSSA)
H. influenzae type B if unvaccinated
Adults
S. aureus
E. coli (rare)
Mycobacterium (extremely rare) |
|
|
Term
Common Pathogens of Contiguous Osteomyelitis |
|
Definition
S. aureus, Strep
E. coli, Proteus
P. aeruginosa (rare)
Anaerobes |
|
|
Term
Duration and Treatment of Osteomyelitis in Children |
|
Definition
Oxacillin
Nafcillin
Cefazolin
Treat for 4-6 weeks
First 2 weeks are IV |
|
|
Term
Duration and Treatment of Osteomyelitis in Adults |
|
Definition
Start with Vancomycin (MRSA is likely)
+/- a G- drug if contiguous (3rd Gen Cephalosporin)
Treat for 4-6 weeks
IV for entire duration |
|
|
Term
If P. aeruginosa is suspected as the pathogen causing Osteomyelitis, you would treat with: |
|
Definition
Anti-Pseudomonal Beta Lactam (Ticarcillin, Piperacillin)
+/- an Aminoglycoside
Ciprofloxacin (levofloxacin) can be converted to PO |
|
|